98 related articles for article (PubMed ID: 6198251)
1. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
[TBL] [Abstract][Full Text] [Related]
3. Nephropathy in the Wiskott-Aldrich syndrome.
Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
[TBL] [Abstract][Full Text] [Related]
4. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
[No Abstract] [Full Text] [Related]
6. Transfer factor therapy: evidence for nonspecificity.
Ballow M; Dupont B; Hansen JA; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
[TBL] [Abstract][Full Text] [Related]
7. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
[No Abstract] [Full Text] [Related]
8. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
Guss RB; McCulley JP
Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
[TBL] [Abstract][Full Text] [Related]
9. [Wiskott-Aldrich syndrome: description of a clinical case].
De Bernardi A; Chessa Ricotti G; Galli L; Funis M
Pediatr Med Chir; 1990; 12(6):691-3. PubMed ID: 2093894
[TBL] [Abstract][Full Text] [Related]
10. [Wiskott-Aldrich syndrome].
Erttmann R; Thöne I; Landbeck G
Monatsschr Kinderheilkd; 1983 Aug; 131(8):524-7. PubMed ID: 6605477
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor].
Balsamo V; Brai M; Mogavero S; Tolone G; La Grutta A
Minerva Pediatr; 1977 Mar; 29(10):651-5. PubMed ID: 875932
[No Abstract] [Full Text] [Related]
12. Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients.
Spitler LE
Am J Med; 1979 Jul; 67(1):59-66. PubMed ID: 463917
[TBL] [Abstract][Full Text] [Related]
13. [Human transfer factor. II. Clinical results with the large pool transfer factor].
Metzner G; Fricke HJ; Schröder D; Göring HD; Franke W; Karl M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):526-39. PubMed ID: 6196269
[TBL] [Abstract][Full Text] [Related]
14. ["Transfer factor". Experimental findings and prospects for its clinical use].
Medunitsyn NV
Patol Fiziol Eksp Ter; 1977; (1):75-80. PubMed ID: 325478
[No Abstract] [Full Text] [Related]
15. [Wiskott-Aldrich syndrome].
Stojimirović E; Cvetković P; Baklaja R; Dujić A; Vuković I
Bilt Hematol Transfuz; 1977; 5(3-4):67-71. PubMed ID: 615612
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of transfer factor treatment of human warts.
Stevens DA; Ferrington RA; Merigan TC; Marinkovich VA
Clin Exp Immunol; 1975 Sep; 21(3):520-4. PubMed ID: 1106927
[TBL] [Abstract][Full Text] [Related]
17. Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term survivor.
Capsoni F; Acerbi L; Bonora G; Perletti L; Ongari AM; Vanoli M; Zanussi C
J Clin Lab Immunol; 1986 Feb; 19(2):91-7. PubMed ID: 3754288
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the antibody dependent cytotoxicity under the effect of transfer factor therapy. Preliminary report].
Láng I; Nékám K; Török K; Gergely P
Orv Hetil; 1979 Jun; 120(25):1491-5. PubMed ID: 471469
[No Abstract] [Full Text] [Related]
19. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
Zabay JM; Fontán G; Campos A; García-Rodriguez MC; Pascual-Salcedo D; Bootello A; de la Concha EG
Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
[TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich syndrome with partial response to transfer factor.
Mackie RM; Alcorn MJ; Stevenson RD; Cochran T; McSween RN
Br J Dermatol; 1978 May; 98(5):567-71. PubMed ID: 656329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
